###begin article-title 0
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Expression of HNF4alpha in the human and rat choroid plexus - Implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 674 679 <span type="species:ncbi:9606">human</span>
###xml 684 687 <span type="species:ncbi:10116">rat</span>
The choroid plexus consists of highly differentiated epithelium and functions as a barrier at the interface of the blood-cerebrospinal-fluid (CSF). This tissue may therefore determine the bioavailability and transport of drugs to the brain. Little is known about the expression of drug and xenobiotic metabolizing enzymes (DME) and of drug transporters in the human choroid plexus. Notably, the transcription factor and zinc finger protein HNF4alpha is a master regulator of DMEs and of drug transporters. As of today its activity in the blood-CSF barrier is unknown. Here we report our efforts in determining HNF4alpha activity in the regulation of ABC transporters in the human and rat choroid plexus.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
We report expression of HNF4alpha by qRT-PCR and by immunohistochemistry and evidence transcript expression of the ATP-binding cassette transporters ABCB1, ABCB4, ABCC1-6 in choroid plexus. Additionally, HNF4alpha DNA binding activity at regulatory sequences of ABCB4 and ABCC1 was determined by EMSA bandshift assays with a specific antibody. We then performed siRNA mediated functional knock down of HNF4alpha in Caco-2 cells and found ABCC1 gene expression to be repressed in cell culture experiments.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Our study evidences activity of HNF4alpha in human and rat choroid plexus. This transcription factor targets DMEs and drug transporters and may well determine availability of drugs at the blood-CSF barrier.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 861 862 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1535 1536 1535 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1537 1538 1537 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1624 1629 <span type="species:ncbi:9606">human</span>
Drug delivery to the brain is mediated by several factors, most notably transport across the blood brain (BB) and the choroid plexus barrier; the latter displays drug-metabolizing enzyme and drug transport activity. It may therefore determine the overall cerebral bioavailability of drugs [1]. Specifically, the choroid plexus is located within brain vesicles. It is composed of a tight monolayer of polarized epithelial cells and forms the blood-cerebrospinal-fluid (CSF) barrier. Together with the blood-brain barrier, formed by endothelial cells of brain capillaries, it functions as the main interface between the central nervous system (CNS) and the peripheral circulation. Within the CNS this tissue is of great pharmacological interest, but information on the expression of efflux transporters such as the ATP binding cassette (ABC) proteins is missing [2]. In contrast, their expression in liver, kidney, and intestine has been studied in considerable detail [3-5]. Indeed, the ABC drug transporters extrude a variety of structurally diverse drugs, drug conjugates and metabolites in an active, ATP-dependent manner and even against high concentration gradients. The three main ABC families considered to be involved in the disposition of xenobiotics include the ABCB family (MDR subfamily, multidrug resistance, e.g. ABCB1/MDR1), the ABCC family of multidrug resistance proteins (MRP subfamily, multidrug resistance related proteins, e.g. ABCC2/MRP2), and the breast cancer resistance protein (ABCG2/BCRP) of the ABCG family [3,4]. However, comprehensive studies on the expression levels of ATP transporters in the human choroid plexus have not been attempted.
###end p 9
###begin p 10
###xml 232 233 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 234 235 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 348 349 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 350 352 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 385 387 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 409 411 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 469 471 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 504 506 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 529 535 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC2 </italic>
###xml 536 538 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 541 547 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC6 </italic>
###xml 548 550 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 553 559 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCG5 </italic>
###xml 560 562 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 568 574 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCG8 </italic>
###xml 575 577 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 942 947 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB </italic>
###xml 951 956 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC </italic>
###xml 1062 1068 1038 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 817 822 <span type="species:ncbi:9606">human</span>
###xml 827 830 <span type="species:ncbi:10116">rat</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
Notably, there is clear evidence for HNF4alpha to play a role in the transcriptional control of drug transporters. Specifically, HNF4alpha is a member of the nuclear receptor superfamily and one of the key players in liver biology [6-8]. Among the genes regulated by HNF4alpha are a broad range of xenobiotic-metabolizing cytochrome P450 isozymes [9,10], UDP-glucuronosyltransferases [11], sulfotransferases [12] and transporters including organic anion transporter 2 [13], organic cation transporter 1 [14], the ABC transporter ABCC2 [15], ABCC6 [16], ABCG5 [17] and ABCG8 [17]. Although there is clear evidence for HNF4alpha to be of key importance in the control of drug metabolism it may also play a role in the regulation of transporters in the choroid plexus. Here we report our efforts in mapping HNF4alpha to human and rat choroid plexus. We determined HNF4alpha DNA binding activity and searched for transcript expression of various ABCB and ABCC transporters in the human choroid plexus. Apart from qRT-PCR and immunohistochemistry studies we evidence ABCC1 gene expression to be highly dependent on HNF4alpha as determined in functional knock down studies. Overall, we provide evidence for HNF4alpha to be an important regulator of ABC drug transporters in the choroid plexus and thus may impact efficacy of pharmacotherapy targeted to the brain.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 27 37 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 136 146 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 188 190 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 202 212 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 343 345 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 386 396 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 495 496 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 571 575 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2</italic>
###xml 593 596 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TTR</italic>
###xml 627 633 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FOXJ1 </italic>
###xml 693 695 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 696 698 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 799 803 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2</italic>
###xml 805 809 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TTR </italic>
###xml 813 819 797 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FOXJ1 </italic>
###xml 892 894 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1380 1382 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1416 1418 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1511 1516 1487 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, D</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 424 427 <span type="species:ncbi:10116">rat</span>
###xml 822 827 <span type="species:ncbi:9606">human</span>
###xml 1092 1097 <span type="species:ncbi:9606">human</span>
###xml 1365 1370 <span type="species:ncbi:9606">human</span>
###xml 1388 1391 <span type="species:ncbi:10116">rat</span>
Initially, we searched for HNF4alpha transcripts in individual samples of human and rat choroid plexus and confirmed gene expression of HNF4alpha by quantitative real time RT-PCR (Figures 1A). We found HNF4alpha transcript expression in human and rat choroid plexus to account for approximately a tenth of its expression in the liver (Figures 1A). It is of considerable importance that HNF4alpha expression in the human and rat choroid plexus is restricted to P1 promoter driven isoforms (Table 1). Furthermore, we studied expression of the insulin-like growth factor 2 (IGF2), transthyretin (TTR) and the transcription factor FOXJ1 to further qualify choroidal epithelial cells of the brain [18,19]. These transcripts are specifically enriched in choroid plexus. We observed abundant expression of IGF2, TTR and FOXJ1 in human choroid plexus as compared to total brain RNA extracts (Figures 1B). There is the need to study histological well qualified tissue, as studies with total brain RNA extracts would render findings meaningless as will be discussed later on. Unfortunately, sufficient human choroid plexus tissue suitable for the harvest of nuclear protein and to perform western blotting as well as EMSA assay could not be obtained. We nonetheless demonstrate HNF4alpha protein expression by immunohistochemistry by use of a specific HNF4alpha antibody for human (Figures 2A) and rat choroid plexus (Figures 2C). To confirm specificity an excess of antigen preabsorbed to the antibody was used (Figures 2B, D).
###end p 12
###begin p 13
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
HNF4alpha isoform expression in human and rat choroid plexus.
###end p 13
###begin p 14
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 61 64 <span type="species:ncbi:10116">rat</span>
###xml 223 230 <span type="species:ncbi:9606">Patient</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
###xml 363 367 <span type="species:ncbi:10116">rats</span>
HNF4alphaP1 and P2 gene expression was measured in human and rat choroid plexus (n = 3, respectively) by real-time quantitative RT-PCR and computed relative to expression of mitATPase6, which served as a housekeeping gene. Patient characteristics are given in Table 5. Caco-2 cells and pancreatic tissue served as controls for HNF4alphaP2 expression in human and rats, respectively.
###end p 14
###begin p 15
###xml 0 81 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression of HNF4&#945; and different ABC transporters in the choroid plexus</bold>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 216 219 <span type="species:ncbi:10116">rat</span>
###xml 590 595 <span type="species:ncbi:9606">human</span>
Gene expression of HNF4alpha and different ABC transporters in the choroid plexus. Gene expression of HNF4alpha and different ABC transporters in the choroid plexus. A: HNF4alpha gene expression in human (n = 3) and rat choroid plexus (n = 3) was measured by quantitative real-time RT-PCR and determined relative to expression of mitATPase6, which served as a housekeeping gene. Expression levels were compared to liver and total brain. Mean values + SD are shown. B and C: Gene expression of FOXJ1, IGF2 and TTR (B) and of different members of the ABCB and ABCC family (C) was analyzed in human choroid plexus by quantitative real-time RT-PCR and determined relative to expression of mitATPase6, which served as a housekeeping gene. Expression levels were compared to liver (n = 4) and total brain. Mean values + SD are shown.
###end p 15
###begin p 16
###xml 0 64 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemical detection of HNF4&#945; in the choroid plexus</bold>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
###xml 386 393 <span type="species:ncbi:9606">Patient</span>
###xml 449 456 <span type="species:ncbi:9606">patient</span>
Immunohistochemical detection of HNF4alpha in the choroid plexus. Slices of human (A, B) and rat (C, D) choroid plexus probes were stained with polyclonal antibodies against HNF4alpha. Arrows indicate representative HNF4alpha positive cells (A, C). To confirm specificity of the immunohistochemical localization antibodies were preabsorbed with excess of antigens for HNF4alpha (B, D). Patient identification numbers were indicated respectively and patient characteristics are given in Table 5. Magnification x400.
###end p 16
###begin p 17
###xml 314 356 314 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 (MDR2/3), ABCC1 (MRP1), ABCC2 (MRP2)</italic>
###xml 358 399 358 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC3 (MRP3), ABCC4 (MRP4), ABCC5 (MRP5) </italic>
###xml 403 416 403 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC6 (MRP6) </italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 553 566 553 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB1 (MDR1) </italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
We then analyzed expression of different members of the ABCB (MDR subfamily, multidrug resistance)/ABCC (MRP subfamily, multidrug resistance related) gene families in the human choroid plexus by quantitative real time RT-PCR and report results for n = 3 individual human choroid plexus samples. mRNA expression of ABCB4 (MDR2/3), ABCC1 (MRP1), ABCC2 (MRP2), ABCC3 (MRP3), ABCC4 (MRP4), ABCC5 (MRP5) and ABCC6 (MRP6) was comparable to its expression level in commercially available control total human brain RNA extracts (Figures 1C). mRNA expression of ABCB1 (MDR1) determined in choroidal epithelium was lower than in human liver (n = 4) and in brain (Figures 1C).
###end p 17
###begin p 18
###xml 316 322 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 412 418 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 434 435 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 512 514 508 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 614 620 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 671 677 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 763 772 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1&#945;</italic>
###xml 1141 1143 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1302 1304 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1330 1332 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1394 1403 1366 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1&#945;</italic>
###xml 1502 1508 1466 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 1512 1518 1476 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 1527 1529 1491 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1690 1696 1650 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 1700 1706 1660 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 1903 1909 1863 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 1913 1919 1873 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 1944 1945 1904 1905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 2054 2055 2014 2015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 2077 2079 2037 2039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2084 2086 2044 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 2158 2164 2114 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 2168 2174 2124 2130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 608 613 <span type="species:ncbi:9606">human</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 918 923 <span type="species:ncbi:9606">human</span>
###xml 1060 1065 <span type="species:ncbi:9606">human</span>
###xml 1669 1674 <span type="species:ncbi:9606">human</span>
###xml 1676 1679 <span type="species:ncbi:10116">rat</span>
###xml 1684 1689 <span type="species:ncbi:10090">mouse</span>
###xml 1889 1892 <span type="species:ncbi:10116">rat</span>
###xml 1897 1902 <span type="species:ncbi:10090">mouse</span>
###xml 2144 2147 <span type="species:ncbi:10116">rat</span>
###xml 2152 2157 <span type="species:ncbi:10090">mouse</span>
We then searched for HNF4alpha binding sites in proximal promoter sequences (up to -7000 bp) of drug transporter coding genes. For this purpose, we used two different bioinformatic approaches (see Material and Methods section for a description of the employed algorithms). We observed three binding sites within the ABCB4 promoter, spaced approximately by 600 bp and 1600 bp and two recognition sites within the ABCC1 promoter (Table 2). Predicted binding sites were confirmed by EMSA band shift assays. We used 32P-labeled double-stranded DNA probes to specifically probe for HNF4alpha-sites located in the human ABCB4 (hABCB4_1, hABCB4_2 and hABCB4_3) and in the human ABCC1 (hABCC1_1, hABCC1_2) gene. Note, DNA binding of nuclear extracts to the A-site of the HNF1alpha-promoter (HNF1pro) served as a positive control. This site is an established recognition site for HNF4alpha. Unfortunately, sufficient amount of human choroid plexus suitable for the isolation of nuclear protein could not be obtained. Instead, we used nuclear extracts isolated from the human intestinal cell line Caco-2 which expresses several ABC transporter genes [20] and therefore is a rich source of HNF4alpha nuclear protein. Indeed, HNF4alpha protein expression in Caco-2 cells is comparable to organs such as the liver [21]. As depicted in Figures 3A we observed strong binding of HNF4alpha to the A-site of the HNF1alpha-promoter. We also observed strong binding of HNF4alpha to the predicted sites in the promoters of ABCB4 and ABCC1 (Figures 3A); bands could be shifted with a specific HNF4alpha antibody therefore demonstrating selectivity and specificity of the assay. Alignment of human, rat and mouse ABCB4 and ABCC1 genes did not identify common HNF4alpha binding sites. This points to differences in the molecular organization of ABC promoters in orthologous genes. HNF4alpha binding sites for the rat and mouse ABCB4 and ABCC1 genes are given in Table 2, whereas the sequences of oligonucleotides to confirm the predicted sites experimentally are shown in Table 3. As shown in Figures 3B and 3C EMSA band shift assays confirmed binding of HNF4alpha to rat and mouse ABCB4 and ABCC1 targeted sequences.
###end p 18
###begin p 19
Predicted binding sites for HNF4alpha in ABC genes.
###end p 19
###begin p 20
Transfac matrix (V$HNF4_01) or self-generated matrix (V$zemlin13_11045) with a setting of core and matrix similarity 0.9 was used.
###end p 20
###begin p 21
Shift-probes sequences.
###end p 21
###begin p 22
The central five nucleotides of the HNF4alpha binding site are highlighted in bold letters. The two direct repeats (DR1) separated by a spacer of one nucleotide are underlined.
###end p 22
###begin p 23
###xml 0 49 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; binding to promoters of ABCB4 and ABCC1</bold>
###xml 314 316 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 262 267 <span type="species:ncbi:9606">human</span>
###xml 273 276 <span type="species:ncbi:10116">rat</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
HNF4alpha binding to promoters of ABCB4 and ABCC1. Electrophoretic mobility shift assays with 2,5 mug Caco-2 cell nuclear extract and oligonucleotides corresponding to the A-site of the HNF1alpha promoter (HNF1pro) and to putative HNF4alpha binding-sites within human (A), rat (B) and mouse (C) ABCB4 and ABCC1 as 32P labeled probe. In supershift assays an antibody directed against HNF4alpha (+) was added. For oligonucleotide sequence information see Table 2 and 3.
###end p 23
###begin p 24
###xml 246 252 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 259 260 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 315 326 307 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mitATPase6 </italic>
###xml 374 376 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 402 408 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 442 448 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 168 173 <span type="species:ncbi:9606">human</span>
To further probe for the role of HNF4alpha in ABC gene regulation we employed an siRNA approach. Specifically, siRNA-mediated functional knock down of HNF4alpha in the human Caco-2 cell line resulted in significantly decreased gene expression of ABCC1 (Table 4; for transfection efficiency and stable expression of mitATPase6 after transfection see Niehof and Borlak, 2008 [22]). These results confirm ABCC1 to be a gene target of HNF4alpha. ABCB4 expression in Caco-2 cells is near the limit of detection. Consequently, knockdown experiments are not meaningful.
###end p 24
###begin p 25
###xml 50 55 <span type="species:ncbi:9606">human</span>
Functional knock down of HNF4alpha in cultures of human Caco-2 cells.
###end p 25
###begin p 26
###xml 57 59 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 388 389 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
Functional knock down of HNF4alpha was already reported [22]. * A student's t test was done to compare HNF4alpha siRNA transfection against negative siRNA transfected controls. The results were considered significant when the p value was less than 0.05. Gene expression was determined by real-time quantitaive RT-PCR in triplicates; mitATPase6 served as housekeeping gene. The DeltaDeltaCT-method was used to determine repression of gene expression. Values for HNF4alpha siRNA transfection represent transcript abundance relative to negative siRNA transfected controls, which were set to 100%.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 349 355 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 359 365 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 670 671 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 672 673 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 674 676 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 677 679 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 748 750 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 751 753 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1285 1286 1253 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1635 1637 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1723 1725 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1726 1728 1674 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1805 1807 1753 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2114 2124 2054 2064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2, TTR </italic>
###xml 2128 2134 2068 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FOXJ1 </italic>
###xml 2221 2223 2161 2163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2224 2226 2164 2166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2344 2354 2284 2290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 2425 2426 2361 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 2467 2477 2403 2409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 2586 2596 2518 2524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF4&#945; </italic>
###xml 1509 1514 <span type="species:ncbi:10090">mouse</span>
###xml 1681 1686 <span type="species:ncbi:10090">mouse</span>
###xml 1691 1696 <span type="species:ncbi:9606">human</span>
###xml 1761 1766 <span type="species:ncbi:9606">human</span>
###xml 1962 1967 <span type="species:ncbi:9606">human</span>
###xml 1972 1975 <span type="species:ncbi:10116">rat</span>
###xml 2502 2507 <span type="species:ncbi:9606">human</span>
###xml 2512 2515 <span type="species:ncbi:10116">rat</span>
###xml 2827 2835 <span type="species:ncbi:9606">patients</span>
Our study aimed for a better understanding of the role of HNF4alpha in the regulation of drug transporters. Here we present evidence for expression of HNF4alpha in the epithelium of the CSF barrier. By applying position weight matrices to genomic sequences of ABC transporters we were able to predict HNF4alpha binding sites in the promoters of the ABCB4 and ABCC1 gene. The predicted binding sites were then confirmed by EMSA band shift assays. We propose a role for HNF4alpha in the regulation of drug transporters of the choroid plexus. Notably, HNF4alpha is a key player in the regulation of genes coding for various metabolic pathways and of xenobiotic metabolism [6-9,23,24]. This protein also promotes expression of an epithelial phenotype [25-27]. Specifically, epithelium of the choroid plexus cells is highly differentiated and functions as a blood-CSF barrier. The expression of HNF4alpha in the epithelium of the choroid plexus and its DNA binding to regulatory sequences of drug transporters is a novel finding. Its expression accounts for approximately a tenth of HNF4alpha expression found in liver. Furthermore, there is evidence for HNF4alpha to undergo alternative splicing with isoforms may arising from alternative splicing and/or usage of two different promoters [6]. Specifically, the P1 promoter generates six different isoforms (HNF4alpha1-alpha6); but activation of the P2 promoter results in isoforms HNF4alpha7-alpha9. P2 promoter-driven HNF4alpha isoforms are expressed throughout mouse liver development, but disappear after birth, while P1 promoter-driven transcripts are abundantly expressed postnataly [28]. Additionally, P2 isoforms are induced in mouse and human hepatocellular carcinoma [29,30] and are primarily expressed in human pancreatic islets and exocrine cells [31]. In the case of the choroid plexus it appears that expression of HNF4alpha is restricted to P1 promoter-driven isoforms. HNF4alpha protein expression in human and rat choroid plexus could be clearly evidenced by immunohistochemistry. To further qualify tissue preparations of choroid plexus expression of IGF2, TTR and FOXJ1 was investigated; their expression are accepted genetic markers of the choroid plexus [18,19]. We validated tissue preparations by morphological and genetic markers. Unlike previous studies where expression of HNF4alpha transcripts could not be evidenced in total RNA extracts of the brain [6], we were able to confirm expression of HNF4alpha in the choroid plexus of human and rat brain. Most certainly, total brain RNA extracts dilute copy number of HNF4alpha transcripts to presumable levels below the limit of detection. Here, we evidence binding of HNF4alpha to regulatory sequences of drug transporters expressed in the choroid plexus and analyzed gene expression of ABC transporters in patients with different causes of death, but the functional significance of the newly identified HNF4alpha binding sites in activating the ABCB4 and ABCC1 promoters still needs to be established.
###end p 28
###begin p 29
###xml 91 93 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1084 1086 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1149 1151 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1427 1429 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1430 1432 1398 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1569 1570 1533 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 166 169 <span type="species:ncbi:10116">rat</span>
###xml 205 209 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 246 261 <span type="species:ncbi:10090">transgenic mice</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
###xml 994 997 <span type="species:ncbi:10116">rat</span>
###xml 1527 1532 <span type="species:ncbi:9606">human</span>
###xml 1537 1540 <span type="species:ncbi:10116">rat</span>
In the past attempts to detect HNF4alpha DNA binding in a choroid plexus papilloma failed [32]. The investigators performed EMSA experiments with nuclear extracts of rat liver, kidney and intestine and of SV40-induced choroid plexus papilloma of transgenic mice, but unfortunately probed for HNF4alpha binding with an oligonucleotide corresponding to the HNF4alpha binding site in the mouse TTR (transthyretin) promoter. The authors did not employ an antibody in EMSA band shift assays; instead, competition with excess of unlabeled probes was done. Although the authors described a weak binding of HNF4alpha with nuclear extracts from kidney they considered intestine as well as choroid plexus as deficient for HNF4alpha binding. There is a need to consider tissue specific DNA binding activity. HNF4alpha binding at the TTR promoter is much less as compared to the A-site in the HNF1 promoter (not exceeding a tenth, data not shown). As detailed above, HNF4alpha gene expression in human and rat choroid plexus is approximately one tenth of its expression in the liver (see Figures 1A). It is therefore not surprising that previous investigators [32] failed to detect HNF4alpha protein in intestine and choroid plexus, even though the authors described weak expression of this protein in kidney. By now, it is well established that HNF4alpha expression is not restricted to liver, but also functions in kidney and intestine [33,34]. Here we evidence by immunohistochemical staining HNF4alpha to be expressed in epithelium of human and rat choroid plexus (see Figures 2).
###end p 29
###begin p 30
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1286 1291 1286 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB1</italic>
###xml 1362 1363 1362 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1542 1544 1542 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1636 1638 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1654 1660 1654 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 1883 1885 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1904 1917 1904 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB1, ABCB4 </italic>
###xml 2018 2024 2018 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB4 </italic>
###xml 2090 2092 2090 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2319 2321 2319 2321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2512 2513 2512 2513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1399 1404 <span type="species:ncbi:9606">human</span>
###xml 1536 1540 <span type="species:ncbi:10116">rats</span>
###xml 1572 1575 <span type="species:ncbi:10116">rat</span>
###xml 1577 1582 <span type="species:ncbi:10090">mouse</span>
###xml 1587 1592 <span type="species:ncbi:9606">human</span>
###xml 1947 1952 <span type="species:ncbi:9606">human</span>
###xml 2085 2088 <span type="species:ncbi:10116">rat</span>
###xml 2175 2180 <span type="species:ncbi:9606">human</span>
###xml 2250 2253 <span type="species:ncbi:10116">rat</span>
Notably, the choroid plexus functions as a barrier for drug uptake to the brain. This tissue expresses drug metabolizing enzymes (DMEs) and some transporters [1]. Expression of DMEs in the choroid plexus is part of a defense program to prevent entry of xenobiotics into the brain. The blood-CSF barrier also regulates entry and distribution of various pharmacologically active compounds between the blood and the CSF interface and is basically involved in numerous exchange processes thereby determining the supply of the brain with nutrients and hormones [1]. Indeed, endogenous metabolites, as well as neurotransmitter and metabolites from the brain are cleared via this barrier [19]. In drug therapies efflux transporters of the ABC-family are of pivotal importance in determining therapeutic tissue levels. In the past research focused on their regulation in liver, kidney and intestine [3,4]. The knowledge on drug transporter in specialized tissues of the brain is incomplete. Specifically, ABCB (MDR) proteins accept a broad range of substrates and may transport large lipophilic, neutral or cationic compounds. This includes a vast number of neuropharmacological drugs such as antiepileptic and antiviral drugs, antidepressants, opiods, antipsychotics and tranquilizer [35-40]. ABCB1, a transporter with highest expression in the gastrointestinal tract [4,41], is expressed at low levels in human choroid plexus, that is much lower than in liver and total brain. Our findings are consistent with results reported previously for rats [42]. Its apical expression in rat, mouse and human choroidal epithelium was shown previously [43]. Furthermore, ABCB4 is highly expressed in the liver, where it is acting as a "flippase" in transporting phospholipids into the bile, but ABCB4 can also bind and transport a subset of ABCB1 substrates with an overlap in substrate specificity [44]. As reported for ABCB1, ABCB4 is expressed at low levels in human choroid plexus, i.e. more than 500 fold lower than in liver. Low ABCB4 expression was also evidenced in choroidal epithelium of the rat [42], but to the best of our knowledge our study is the first report on expression in human choroid plexus. An apical distribution of ABCB1 in neonatal cultured rat choroid plexus cells imply a drug transport from blood into CSF [43]. In endothelial cells of small blood capillaries of the blood-brain barrier, apical located ABCB1 pumps drugs back into the blood stream and therefore limits drug penetration to the brain [2].
###end p 30
###begin p 31
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1-6 </italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 316 322 316 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1 </italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 359 372 359 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC1, ABCC4 </italic>
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC5 </italic>
###xml 471 484 471 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC2, ABCC3 </italic>
###xml 488 494 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC6 </italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC </italic>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 271 274 <span type="species:ncbi:10116">rat</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 607 610 <span type="species:ncbi:10116">rat</span>
###xml 1314 1319 <span type="species:ncbi:9606">human</span>
Likewise, the ABCC (MRP) proteins are multispecific organic anion transporters and accept glucurono-, glutathione- and sulfo-conjugates. They transport physiological substrate conjugates as well as drug conjugates. Expression of ABCC1-6 mRNA transcripts was reported for rat choroid plexus [42] as was expression of ABCC1 for human choroid plexus [43,45,46]. ABCC1, ABCC4 and ABCC5 were expressed in human choroid plexus at least at 10 fold higher than in liver; whereas ABCC2, ABCC3 and ABCC6 were expressed up to 800 fold lower than liver. Similar results were reported for ABCC transporter expression in rat choroid plexus [42]. Notably, ABCC1 is localized at the basolateral membrane of choroid plexus [43,45,46], but Gazzin et al [46] described a major difference in the localization of ABCB1 and ABCC1 proteins between the blood-brain and the blood-CSF barrier with strongest expression of ABCC1 at the choroidal epithelium. Indeed, ABCC proteins contribute to the protective role of the choroid plexus and mediate basolateral efflux of conjugates resulting from choroidal drug metabolism into the blood. Although it is known that the choroid plexus is important in regulating the distribution of various pharmacologically active compounds between the blood and the CSF, the characterization of the involved human ABC transporters gives new insights into the function of the CSF barrier.
###end p 31
###begin p 32
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 691 704 691 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCB1, ABCB4 </italic>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ABCC4 </italic>
###xml 821 823 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1008 1010 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 742 747 <span type="species:ncbi:9606">human</span>
###xml 926 931 <span type="species:ncbi:9606">human</span>
Furthermore, ABCBs (MDRs) and ABCCs (MRPs) are inducible transporters and are highly responsive to chemotherapeutics, carcinogens, inflammation, heat shock, hypoxia and irradiation [47]. They are regulated by a complex network of transcriptional cascades, such as by multiple ligand activated nuclear receptors like retinoid X receptor (RXR), farnesoid X receptor (FXR), constitutive androstane receptor (CAR) and the xenobiotic receptor pregnane X receptor (PXR) [47,48]. There is also evidence for the transcription factors AP-1, p53, Egr-1 and WT-1 to participate in their regulation with NF-Y, Sp1 and Sp3 being involved in the constitutive expression [47]. Recently, an upregulation of ABCB1, ABCB4 and ABCC4 transcripts was reported in human embryonic kidney cells that conditionally expressed wild-type HNF4alpha [33]. An important role of HNF4alpha in the transcriptional control of drug transporters was reported for human hepatocytes as determined by adenoviral HNF4alpha-siRNA mediated knockdown [49]. We also employed an siRNA mediated functional knockdown of HNF4alpha and found ABCC1 gene expression to be massively repressed. There is a need to improve an understanding of the mechanism by which transporters are regulated. This will impact the design of novel CNS therapeutics. Targeting transporters may thus be useful in achieving therapeutic tissue levels of CNS drugs.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 69 72 <span type="species:ncbi:10116">rat</span>
We report expression of HNF4alpha in choroid plexus of the human and rat brain. This factor might regulate expression of some ATP binding cassette transporters. Targeting of HNF4alpha may impact efficacy of pharmacotherapy of CNS drugs.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
Human and rat tissue
###end title 36
###begin p 37
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 275 280 <span type="species:ncbi:9606">human</span>
###xml 436 441 <span type="species:ncbi:9606">Human</span>
###xml 500 508 <span type="species:ncbi:9606">patients</span>
###xml 679 686 <span type="species:ncbi:9606">Patient</span>
###xml 733 738 <span type="species:ncbi:9606">human</span>
A total of n = 7 human and n = 7 rat tissues were analyzed. Samples of human choroid plexus (n = 3, gene expression analysis) were kindly provided by T. Arendt (Department of Neuroanatomy, Paul-Flechsig-Institute, University of Leipzig, Germany). Paraffin-embedded slices of human choroid plexus for immunohistochemistry (n = 4) were kindly provided by C. Grothe (Institute of Neuroanatomy, Hannover Medical School, Hannover, Germany). Human liver tissue (gene expression analysis) was obtained from patients undergoing hepatic resections and were kindly provided by J. Klempnauer (Department of Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany). Patient characteristics are given in Table 5. Control human brain RNA was purchased from BD Biosciences (Heidelberg, Germany).
###end p 37
###begin p 38
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics.
###end p 38
###begin p 39
###xml 11 14 <span type="species:ncbi:10116">rat</span>
###xml 53 57 <span type="species:ncbi:10116">rats</span>
###xml 210 213 <span type="species:ncbi:10116">rat</span>
###xml 246 250 <span type="species:ncbi:10116">rats</span>
###xml 331 334 <span type="species:ncbi:10116">rat</span>
###xml 357 361 <span type="species:ncbi:10116">rats</span>
Samples of rat choroid plexus (n = 3, Sprague Dawley rats, gene expression analysis) were kindly provided by H. Hilbig and K. Spanel-Borowski (Department of Anatomy, University of Leipzig, Germany). Samples of rat liver and brain (Sprague Dawley rats, gene expression analysis) were generated in-house. Paraffin-embedded slices of rat brain (Sprague Dawley rats) containing choroid plexus regions for immunohistochemistry (n = 4) were kindly provided by C. Grothe (Institute of Neuroanatomy, Hannover Medical School, Hannover, Germany).
###end p 39
###begin title 40
Quantitative real-time RT-PCR
###end title 40
###begin p 41
###xml 1138 1139 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 1716 1717 1703 1704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 189 192 <span type="species:ncbi:10116">rat</span>
###xml 208 211 <span type="species:ncbi:10116">rat</span>
###xml 242 245 <span type="species:ncbi:10116">rat</span>
###xml 262 265 <span type="species:ncbi:10116">rat</span>
Analysis of human samples: Three human choroid plexus samples and four human liver samples were analyzed separately and used for calculation of the mean and standard deviation. Analysis of rat samples: Three rat choroid plexus samples, three rat liver and three rat brain samples were analyzed separately and used for calculation of the mean and standard deviation. Total RNA from choroid plexus and liver was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturers recommendations. Subsequently to RNA isolation, a DNase I digest was performed. 4 mug total RNA from each sample was used for reverse transcription (Omniscript Reverse Transcriptase, Qiagen, Hilden, Germany). Quantitative real-time RT-PCR measurement was done with the Lightcycler (Roche Diagnostics, Mannheim, Germany) with the following conditions: denaturation at 95degreesC, annealing at different temperatures for 8 sec, extension at 72degreesC for different times and detection of SYBR-Green I-fluorescence at different temperatures. Detailed primer specific conditions and oligonucleotide sequence information are given in Table 6. Relative quantification was performed using the "Fit Points Method" of the LightCycler3 Data Analysis Software version 3.5.28 (Roche Diagnostics, Mannheim, Germany) by comparing the sample values to a standard curve within the linear range of amplification. This comparison was performed during each LightCycler Run (for genes of interest as well as for the housekeeping gene, i.e. mitATPase6). The standardized sample values for each gene of interest were divided by the standardized values of the housekeeping gene. The slope of external standard curves are given in Table 6, indicating the PCR efficiency for each amplicon.
###end p 41
###begin p 42
Real-time PCR primer sequences and amplification settings.
###end p 42
###begin title 43
Caco-2 cell culture
###end title 43
###begin p 44
###xml 66 68 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 251 253 247 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 268 270 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Caco-2 cells are a valuable source for HNF4alpha nuclear protein [21] and were obtained from and cultivated as recommended by DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany) and seeded with a density of 4 x 106 cells per 75 cm2 flask and harvested after 11 days of culture.
###end p 44
###begin title 45
Isolation of nuclear extracts
###end title 45
###begin p 46
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 323 324 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 491 493 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 717 718 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 844 846 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1051 1057 1013 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1058 1060 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
Nuclear extracts from Caco-2 cells were isolated by the modified method of Dignam et al [50]. Eleven days after seeding cells were washed twice with ice-cold PBS, scraped into microcentrifuge tubes and centrifuged for 5 min at 2000 x g, 4degreesC. Cell pellets were resuspended in lysis buffer (10 mM Tris pH 7.4, 2 mM MgCl2, 140 mM NaCl, 1 mM DTT, 4 mM Pefabloc, 1% Aprotinin, 40 mM beta-glycerophosphate, 1 mM sodiumorthovanadate and 0.5% TX100) at 4degreesC for 10 min (300 mul for 1 x 107 cells), transferred onto one volume of 50% sucrose in lysis buffer and centrifuged at 14000 x g and 4degreesC for 10 min. Nuclei were resuspended in Dignam C buffer (20 mM Hepes pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 4 mM Pefabloc, 1% Aprotinin, 40 mM beta-glycerophosphate, 1 mM sodiumorthovanadate, 30 mul for 1 x 107 cells) and gently shaked at 4degreesC for 30 min. Nuclear debris was removed by centrifugation at 14000 x g at 4degreesC for 10 min. Protein concentrations were determined according to the method of Smith et al [51]. The extracts were aliquoted and stored at -70degreesC.
###end p 46
###begin title 47
Electrophoretic mobility shift assays
###end title 47
###begin p 48
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 281 283 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 393 394 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 841 850 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNF1&#945;</italic>
###xml 486 492 <span type="species:ncbi:9913">bovine</span>
Forward and reverse oligonucleotides (for sequence information see Table 3) were purchased from MWG Biotech (Ebersberg/Muenchen, Germany), annealed and 32P-labeled using 32PgammaATP and T4-kinase (New England Biolabs, Frankfurt, Germany). 2,5 mug Caco-2 cell nuclear extract and 105 cpm (0.027 ng) radiolabeled probe were incubated in binding buffer consisted of 25 mM HEPES, pH 7.6, 5 mM MgCl2, 34 mM KCl, 2 mM DTT, 2 mM Pefabloc, 2% Aprotinin, 40 ng of poly (dI-dC)/mul and 100 ng of bovine serum albumin/mul for 20 minutes on ice. Free DNA and DNA-protein complexes were resolved on a 6% polyacrylamide gel (acrylamide: bisacrylamide ratio = 37.5:1). Super shift experiments were done with a 1 mug HNF4alpha specific antibody (sc-6556x, Santa Cruz Biotechnology, Heidelberg, Germany). DNA binding of nuclear extracts to the A-site of the HNF1alpha-promoter (HNF1pro) served as a positive control.
###end p 48
###begin title 49
Bioinformatic searches for HNF4alpha binding-sites
###end title 49
###begin p 50
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 725 726 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 868 869 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 781 784 <span type="species:ncbi:10116">rat</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
The transcription start site (TSS, +1) of the NCBI mRNA reference sequence (RefSeq) was aligned using the UCSC Genome Browser  for promoter annotation of the respective genes. Proximal promoters (up to -7000 bp) of human ABCB1, ABCB4 and ABCC1 to ABCC6 were checked for putative HNF4alpha binding-sites with the tool MATCH [52],  by employing two different weight matrix, i.e. V$HNF4_01, Transfac matrix (generated by Biobase) and V$zemlin13-11045 (self-generated). V$zemlin13-11045 is based on a collection of 33 well known HNF4alpha sites and was generated using the matrix generation tool of Biobase . At least one of both matrices has to exceed the cut-off of 0.9 for core similarity and 0.9 for matrix similarity (Table 2). Furthermore, proximal promoters (up to -7000 bp) of rat and mouse ABCB4 and ABCC1 were checked for putative HNF4alpha binding sites (Table 2).
###end p 50
###begin title 51
Immunohistochemistry
###end title 51
###begin p 52
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 78 80 78 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 329 332 <span type="species:ncbi:10116">rat</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 574 585 <span type="species:ncbi:3704">horseradish</span>
The sections were deparaffinized, demasked by heating, incubated with 0,6% H2O2 in methanol for 30 min, and subsequently with protein block serum-free reagent (Dako, Glostrup, Denmark) for 10 min. Incubation with polyclonal antibody (Santa Cruz Biotechnology, Heidelberg, Germany) against HNF4alpha (sc-6556x, 1:400 dilution for rat sections, 1:200 dilution for human sections) was performed for 45 min. The sections were rinsed with Tris-buffered saline, incubated with biotinylated universal secondary antibodies (Dako, Glostrup, Denmark) for 15 min and subsequently with horseradish peroxidase-conjugated streptavidin solution (Dako, Glostrup, Denmark) for 15 min. Labeling was detected using a diaminobenzidine (DAB) chromogen solution (Dako, Glostrup, Denmark) for 5 min. The sections were counterstained with hematoxylin before examination under light microscope. To confirm the specificity of the immunohistochemical localization, antibodies preabsorbed 2 h with a twenty fold excess of antigen for HNF4alpha (sc-6556P, Santa Cruz Biotechnology, Heidelberg, Germany) were used.
###end p 52
###begin title 53
siRNA silencing of HNF4alpha
###end title 53
###begin p 54
###xml 106 108 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 517 519 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human HNF4alpha-specific siRNA probes were purchased from Qiagen (Hilden, Germany). Caco-2 cells (1,5 x 105 cells/well in 24-well plate) were transfected in triplicate for 48 h with 25 nM of the siRNA duplex using HiPerFect transfection reagent (Qiagen, Hilden, Germany). Alexa-Fluor488 labeld siRNA (Qiagen, Hilden Germany) was used as negative siRNA and as positive control for transfection efficiency. For transfection efficiency and stable expression of mitATPase6 after transfection see Niehof and Borlak, 2008 [22].
###end p 54
###begin title 55
Abbreviations
###end title 55
###begin p 56
ABC transporter: ATP-binding cassette transporter; CSF: cerebrospinal fluid; DME: drug metabolizing enzymes; EMSA: electrophoretic mobility shift assay; HNF: hepatocyte nuclear factor; MDR: multidrug resistance gene family (ABCB); MRP: multidrug resistance related proteins gene family (ABCC); TTR: transthyretin.
###end p 56
###begin title 57
Authors' contributions
###end title 57
###begin p 58
JB designed the entire study, supervised the experimental works and is responsible for the final writing of the manuscript, MN supervised the experiments and prepared the initial draft of the manuscript. Both authors read and approved the final manuscript.
###end p 58
###begin title 59
Acknowledgements
###end title 59
###begin p 60
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 333 336 <span type="species:ncbi:10116">rat</span>
We thank S. Marschke, A. Pfanne and A. Schulmeyer for valuable technical assistance, S. Reymann and R. Zemlin for assistance in bioinformatics and advice on design of PCR primers, T. Arendt, U. Gartner and C. Grothe for providing samples of human choroid plexus and H. Hilbig, K. Spanel-Borowski and C. Grothe for the preparation of rat choroid plexus. This work was supported by a grant of the Lower Saxony Ministry of Culture and Science to J.B.
###end p 60
###begin article-title 61
Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus
###end article-title 61
###begin article-title 62
Drug transport at the blood-brain barrier and the choroid plexus
###end article-title 62
###begin article-title 63
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
###end article-title 63
###begin article-title 64
The role of ABC transporters in drug resistance, metabolism and toxicity
###end article-title 64
###begin article-title 65
###xml 13 18 <span type="species:ncbi:9606">human</span>
MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions
###end article-title 65
###begin article-title 66
Hepatocyte nuclear factor 4alpha
###end article-title 66
###begin article-title 67
Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression
###end article-title 67
###begin article-title 68
Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis
###end article-title 68
###begin article-title 69
###xml 61 66 <span type="species:ncbi:9606">human</span>
Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting
###end article-title 69
###begin article-title 70
Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription
###end article-title 70
###begin article-title 71
Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha
###end article-title 71
###begin article-title 72
###xml 178 183 <span type="species:ncbi:9606">human</span>
The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase
###end article-title 72
###begin article-title 73
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4{alpha} and suppressed by bile acids
###end article-title 73
###begin article-title 74
###xml 4 9 <span type="species:ncbi:9606">Human</span>
The Human Organic Cation Transporter 1 Gene is Transactivated by Hepatocyte Nuclear Factor-4{alpha}
###end article-title 74
###begin article-title 75
###xml 114 119 <span type="species:ncbi:9606">human</span>
Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)
###end article-title 75
###begin article-title 76
###xml 62 68 <span type="species:ncbi:10090">murine</span>
HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression
###end article-title 76
###begin article-title 77
Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8
###end article-title 77
###begin article-title 78
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo
###end article-title 78
###begin article-title 79
Choroid plexus in the central nervous system: biology and physiopathology
###end article-title 79
###begin article-title 80
Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells
###end article-title 80
###begin article-title 81
###xml 52 55 <span type="species:ncbi:10116">Rat</span>
RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain
###end article-title 81
###begin article-title 82
HNF4{alpha} and the Ca-Channel TRPC1 Are Novel Disease Candidate Genes in Diabetic Nephropathy
###end article-title 82
###begin article-title 83
Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
###end article-title 83
###begin article-title 84
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
###end article-title 84
###begin article-title 85
Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells
###end article-title 85
###begin article-title 86
Activation of p21(CIP1/WAF1) gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha
###end article-title 86
###begin article-title 87
Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver
###end article-title 87
###begin article-title 88
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing
###end article-title 88
###begin article-title 89
EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas
###end article-title 89
###begin article-title 90
###xml 109 114 <span type="species:ncbi:9606">human</span>
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer
###end article-title 90
###begin article-title 91
###xml 102 107 <span type="species:ncbi:9606">human</span>
Genetic evidence that HNF-1{alpha}-dependent transcriptional control of HNF-4{alpha} is essential for human pancreatic {beta} cell function
###end article-title 91
###begin article-title 92
Similarities in transthyretin gene expression and differences in transcription factors: liver and yolk sac compared to choroid plexus
###end article-title 92
###begin article-title 93
HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma
###end article-title 93
###begin article-title 94
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon
###end article-title 94
###begin article-title 95
Role of multidrug transporters in pharmacoresistance to antiepileptic drugs
###end article-title 95
###begin article-title 96
Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity
###end article-title 96
###begin article-title 97
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Variable modulation of opioid brain uptake by P-glycoprotein in mice
###end article-title 97
###begin article-title 98
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds-implications for pharmacokinetics of selected substrates
###end article-title 98
###begin article-title 99
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model
###end article-title 99
###begin article-title 100
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)
###end article-title 100
###begin article-title 101
###xml 80 84 <span type="species:ncbi:10116">rats</span>
Tissue distribution and chemical induction of multiple drug resistance genes in rats
###end article-title 101
###begin article-title 102
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats
###end article-title 102
###begin article-title 103
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
###end article-title 103
###begin article-title 104
MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
###end article-title 104
###begin article-title 105
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
###end article-title 105
###begin article-title 106
Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces
###end article-title 106
###begin article-title 107
Transcriptional regulation of ABC drug transporters
###end article-title 107
###begin article-title 108
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
###end article-title 108
###begin article-title 109
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA
###end article-title 109
###begin article-title 110
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
###end article-title 110
###begin article-title 111
Measurement of protein using bicinchoninic acid
###end article-title 111
###begin article-title 112
A novel computational approach for the prediction of networked transcription factors of aryl hydrocarbon-receptor-regulated genes
###end article-title 112

